Nurse practitioner-led, virtually delivered, motivational enhancement and device support intervention to improve CPAP adherence: A feasibility randomized control trial

Obstructive sleep apnea (OSA) is the most common and costly sleep-related breathing disorder. Over 930 million people worldwide currently have OSA, and approximately  1 in 5 Americans suffer from this chronic health condition.1 The physiologic changes caused by OSA often lead to a range of distressing symptoms (e.g., excessive daytime sleepiness, depression, impairments in memory, attention, and other cognitive domains) and numerous cardiovascular, cerebrovascu lar, and metabolic comorbidities.2,3 These conditions impair social relationships, hinder work performance and safety, increase healthcare utilization, shorten life expectancy, and reduce the overall quality of life3 indicating that OSA remains a common and serious public health threat.
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research